Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANISLEEP
NCT07656350Recruiting
- Sponsor
- King's College London
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised trial of dronabinol and cannabidiol in anxiety disorder (4 arms), sponsored by King's College London. Primary endpoint: Threat-minus-safe tonic skin conductance level difference score. Started Jun 2026; status: recruiting.
02
Drugs
dronabinolcannabidiol
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT07656350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07656350.